Cyclin T1 Antikörper (Internal Region)

Produktnummer ABIN116513

Produktdetails anti-Cyclin T1 Antikörper

Target: Cyclin T1 (CCNT1)

Bindungsspezifität: Internal Region

Reaktivität: Human, Maus, Ratte

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser Cyclin T1 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunoprecipitation (IP), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Enzyme Immunoassay (EIA), Immunohistochemistry (Frozen Sections) (IHC (fro))

Spezifität: Antiserum will specifically react with a 85 kDa cyclin T1 protein. No reaction was observed against other related cyclins.

Aufreinigung: Delipidation and defibrination

Immunogen: Cyclin T1 peptide corresponding to an internal region of the human protein conjugated to Keyhole Limpet Hemocyanin (KLH).

Anwendungsinformationen

Applikationshinweise: Suitable for ELISA, immunoprecipitation, immunohistochemistry, immunoblotting andother immunological methods requiring high titer and specificity. Recommended dilutions: ELISA 1: 1,000 - 1: 5,000Western blot 1: 500 - 1: 2,000Immunohistochemistry 1: 200 - 1: 1,000 (use paraffin embedded tissue).
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 75 mg/mL (by refractometry)

Buffer: 0.02 M Potassium Phosphate, 0.15 M NaCl, pH 7.2, containing 0.01 % sodium azide

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Store at -20 °C to -80 °C. Avoid multiple freeze/thaw cycles.

Details zu Cyclin T1

Target: Cyclin T1 (CCNT1)

Andere Bezeichnung: Cyclin T1 (CCNT1 Produkte)

Synonyme: CG6292 antikoerper, Dmcyclin T antikoerper, Dmel\\CG6292 antikoerper, ORE-14 antikoerper, P-TEFb antikoerper, anon-74EFc antikoerper, dT antikoerper, p124 antikoerper, Cyclin-T1 antikoerper, ccnt antikoerper, cyct1 antikoerper, CCNT antikoerper, CYCT1 antikoerper, HIVE1 antikoerper, 2810478G24Rik antikoerper, AI115585 antikoerper, CycT1 antikoerper, fi75b02 antikoerper, si:dkey-18f23.10 antikoerper, wu:fi75b02 antikoerper, Cyclin T antikoerper, cyclin T1 antikoerper, cyclin T1 L homeolog antikoerper, CycT antikoerper, CCNT1 antikoerper, ccnt1 antikoerper, Ccnt1 antikoerper, ccnt1.L antikoerper

Hintergrund: Cyclin T1, together with the kinase CDK9, is a component of the transcription elongation factor P-TEFb which binds the human immunodeficiency virus type 1 (HIV-1) transactivator Tat. Tat stimulates human HIV-1 viral transcription elongation. This suggests that cyclin T1/cdk9(PITALRE) is one of the HIV-1 required host cellular cofactors generated during T cell activation. Cyclin T1/cdk9(PITALRE) is shown to interact with Tat to restore Tat activation in HeLa nuclear extracts depleted of P-TEFb. P-TEFb facilitates transcription by phosphorylating the carboxy-terminal domain (CTD) of RNA polymerase II. The cdk9(PITALRE) activity and cyclin T1 are essential for activation of transcription when tethered to the heterologous Rev response element RNA via the regulator of expression of virion Rev. Cyclin T1 is an exceptionally large cyclin and is therefore a candidate for interactions with regulatory proteins.Synonyms: CCNT1, CycT1, Cyclin-T, Cyclin-T1

Gen-ID: 904

NCBI Accession: NP_001231

UniProt: O60563